CD274 and melanoma: s with presenting in approximately 40% of melanoma patients37, 8Ourm Areported a similar result: after ing9This may be due to the limited population, but could also be because a single BRAF V600 mutation is not enough to work as the biomarker for anti-PD-1/PD-L1 antibodies.